Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
65.02 USD | -0.25% | -2.05% | +3.57% |
May. 08 | Vaxcyte, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 25 | Vaxcyte Insider Sold Shares Worth $928,845, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.57% | 7.09B | |
+5.05% | 109B | |
+10.86% | 105B | |
-0.38% | 22.25B | |
-11.76% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-9.66% | 16.85B | |
+4.13% | 13.76B | |
+34.81% | 12.46B |
- Stock Market
- Equities
- PCVX Stock
- News Vaxcyte, Inc.
- Vaxcyte Exercises Option for Manufacturing Rights Agreement With Sutro Biopharma; Sutro Shares Jump Premarket